emerging glp-1 gip treatments 2025 new drug retatrutide Treatment with retatrutide, an agonist to GLP-1, GIP, and glucagon What is the pipeline for
Description
Participants in the profile characterized by high GLP-1 and high GIP tertiles achieved low response to both drugs
Our expert team helps patients navigate common side effects like GLP-1 fatigue while maximizing the results of medically supervised weight loss
Aim for at least 0.7 grams of protein per pound of body weight even while traveling
With every injection
How does PlexusDx genetic testing help choose between these medications
Regular readers may recall that GLP-1 receptor agonists were recently introduced for the treatment of diabetes and are currently under investigation for the treatment of obesity
